ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2164

IMPACT of a Systematic Screening of Multimorbidities in Patients with Chronic Inflammatory Rheumatic Diseases

Mégane Beurai-Weber Jr.1, Audrey Jaussent2, Guilhem du Cailar3, Marie-Christine Picot2, François Roubille Sr.4, Jean-David Cohen5, Jacques Morel6, Jean Bousquet7, Pierre Fesler8, Bernard Combe9 and Claire Daien10, 1Rheumatology Department, Lapeyronie Hospital and Montpellier University, MONTPELLIER, France, 2Department of medical information, Lapeyronie Hospital and Montpellier University, MONTPELLIER, France, 3Internal Medicine and Hypertension, Hopital Lapeyronie, Montpellier, France, 4Department of cardiology, Arnaud de Villeneuve Hospital and Montpellier University, MONTPELLIER, France, 5IMMUNO-RHEUMATOLOGY, CHU LAPEYRONIE, MONTPELLIER, France, 6Department of Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France, 7MACVIA-France, Lapeyronie Hospital and Montpellier University, MONTPELLIER, France, 8Internal medicine and hypertension, Lapeyronie Hospital and Montpellier University, Montpellier, France, 9University Hospital Lapeyronie, Department of Rheumatology, Montpellier, France, 10Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, Psoriatic arthritis, Rheumatoid arthritis (RA), spondylarthritis and vaccines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Epidemiology and Public Health Poster III: SLE, SSc, APS, PsA, and Other Rheumatic Diseases

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: EULAR proposes to screen multimorbidities in chronic inflammatory rheumatic diseases. The aim of the study was to assess i) multimorbidities in patients with chronic inflammatory diseases, ii) how patients follow recommendations given after a systematic standardized multimorbidity screening.

Methods: Exams were performed during a 1-day multimorbidity clinic. Diabetes, hypertension, CVD damage, chronic respiratory diseases, osteoporosis and preventive measures were assessed. Advice, complementary exams and prescriptions were provided to patient and general practitioner after this check-up if needed. Patients were called 3 months later to assess the applications of the given recommendations.

Results: Among the 541 patients screened, hypertension was present in 28.1% patients, dyslipidemia in 19.2%, chronic respiratory tract diseases in 12.8% and diabetes in 9.6%. Screening led to the following recommendations: blood pressure monitoring (22.6% patients), dietary advice (56.8%), cardiologist referral (35.5%), intensification of physical activity (27.0%), cancer screening (50.5%), vaccinations (60.6%) and
vitamino-calcium supplementation (30.3%). On the 237 patients called back, 72.3% underwent blood pressure monitoring, 58.6% followed dietary advice, 64.4% took vitamino-calcium supplementation, 55.2% had
vaccinations done, 52.1% saw a cardiologist, 42.7% increased physical activity and 31.4% performed cancer screening. No specific gender, age, pathology, or psychological factors were associated with adherence to
recommendations.

Conclusion: This study underlines the relevance of a systematic screening of multimorbidities in chronic inflammatory rheumatic diseases, and the good patient’s adherence rate to the recommendations. Further information will be found after a follow-up visit provided for all the 1200 patients already screened.


Disclosure: M. Beurai-Weber Jr., None; A. Jaussent, None; G. du Cailar, None; M. C. Picot, None; F. Roubille Sr., None; J. D. Cohen, None; J. Morel, None; J. Bousquet, None; P. Fesler, None; B. Combe, Pfizer, UCB, BMS, Janssen, Lilly, MSD, Roche-Chugai, Abbvie, Novartis, 2, 5, 8; C. Daien, None.

To cite this abstract in AMA style:

Beurai-Weber M Jr., Jaussent A, du Cailar G, Picot MC, Roubille F Sr., Cohen JD, Morel J, Bousquet J, Fesler P, Combe B, Daien C. IMPACT of a Systematic Screening of Multimorbidities in Patients with Chronic Inflammatory Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/impact-of-a-systematic-screening-of-multimorbidities-in-patients-with-chronic-inflammatory-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-a-systematic-screening-of-multimorbidities-in-patients-with-chronic-inflammatory-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology